Novo Nordisks once-daily oral semaglutide has delivered statistically "significant reductions in blood sugar in patinets aged 1017 year, paving the way for a potential label expansion to expand the drug eligible patient pool
Semaglutide vs tirzepatide is not just a patient-facing comparison
While these side effects are well-documented, many people also often report anecdotal adverse events while using GLP-1 drugs
There is no need to take a supplemental dose
It didnt need the usual leader sequence, and it still worked even when we swapped in unusual amino acids
Efficacy of semaglutide in a subcutaneous and an oral formulation, Frontiers in Endocrinology (2021) Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts, Diabetes, Obesity , & Metabolism (2024) Effectiveness of oral versus injectable semaglutide in adults with Type 2 diabetes: Results from a retrospective observational study in Croatia, Diabetology (2024) Drug absorption, Merck Manual Rybelsus label, U.S